The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Acute Lung Injury market was valued at US$ 516.7 million in 2023 and is anticipated to reach US$ 722.9 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema.
This report aims to provide a comprehensive presentation of the global market for Acute Lung Injury, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Lung Injury.
Report Scope
The Acute Lung Injury market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Lung Injury market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Lung Injury companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Altor BioScience
- FirstString Research
- GlaxoSmithKline
- Forschung und Entwicklung
- Commence Bio
- CompleGen
- Histocell S.L.
- Stemedica Cell Technologies
- Windtree Therapeutics
- S-Evans Biosciences
Segment by Type
- Pharmacotherapy
- Mechanical Ventilation
- Adjunctive Procedures
- Fluid Management
- Others
Segment by Application
- Hospitals
- Clinics
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Lung Injury companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Lung Injury Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pharmacotherapy
1.2.3 Mechanical Ventilation
1.2.4 Adjunctive Procedures
1.2.5 Fluid Management
1.2.6 Others
1.3 Market by Application
1.3.1 Global Acute Lung Injury Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Lung Injury Market Perspective (2019-2030)
2.2 Acute Lung Injury Growth Trends by Region
2.2.1 Global Acute Lung Injury Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acute Lung Injury Historic Market Size by Region (2019-2024)
2.2.3 Acute Lung Injury Forecasted Market Size by Region (2025-2030)
2.3 Acute Lung Injury Market Dynamics
2.3.1 Acute Lung Injury Industry Trends
2.3.2 Acute Lung Injury Market Drivers
2.3.3 Acute Lung Injury Market Challenges
2.3.4 Acute Lung Injury Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Lung Injury Players by Revenue
3.1.1 Global Top Acute Lung Injury Players by Revenue (2019-2024)
3.1.2 Global Acute Lung Injury Revenue Market Share by Players (2019-2024)
3.2 Global Acute Lung Injury Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Lung Injury Revenue
3.4 Global Acute Lung Injury Market Concentration Ratio
3.4.1 Global Acute Lung Injury Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Lung Injury Revenue in 2023
3.5 Acute Lung Injury Key Players Head office and Area Served
3.6 Key Players Acute Lung Injury Product Solution and Service
3.7 Date of Enter into Acute Lung Injury Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Lung Injury Breakdown Data by Type
4.1 Global Acute Lung Injury Historic Market Size by Type (2019-2024)
4.2 Global Acute Lung Injury Forecasted Market Size by Type (2025-2030)
5 Acute Lung Injury Breakdown Data by Application
5.1 Global Acute Lung Injury Historic Market Size by Application (2019-2024)
5.2 Global Acute Lung Injury Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acute Lung Injury Market Size (2019-2030)
6.2 North America Acute Lung Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acute Lung Injury Market Size by Country (2019-2024)
6.4 North America Acute Lung Injury Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Lung Injury Market Size (2019-2030)
7.2 Europe Acute Lung Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acute Lung Injury Market Size by Country (2019-2024)
7.4 Europe Acute Lung Injury Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Lung Injury Market Size (2019-2030)
8.2 Asia-Pacific Acute Lung Injury Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acute Lung Injury Market Size by Region (2019-2024)
8.4 Asia-Pacific Acute Lung Injury Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Lung Injury Market Size (2019-2030)
9.2 Latin America Acute Lung Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acute Lung Injury Market Size by Country (2019-2024)
9.4 Latin America Acute Lung Injury Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Lung Injury Market Size (2019-2030)
10.2 Middle East & Africa Acute Lung Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acute Lung Injury Market Size by Country (2019-2024)
10.4 Middle East & Africa Acute Lung Injury Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Altor BioScience
11.1.1 Altor BioScience Company Detail
11.1.2 Altor BioScience Business Overview
11.1.3 Altor BioScience Acute Lung Injury Introduction
11.1.4 Altor BioScience Revenue in Acute Lung Injury Business (2019-2024)
11.1.5 Altor BioScience Recent Development
11.2 FirstString Research
11.2.1 FirstString Research Company Detail
11.2.2 FirstString Research Business Overview
11.2.3 FirstString Research Acute Lung Injury Introduction
11.2.4 FirstString Research Revenue in Acute Lung Injury Business (2019-2024)
11.2.5 FirstString Research Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Acute Lung Injury Introduction
11.3.4 GlaxoSmithKline Revenue in Acute Lung Injury Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Forschung und Entwicklung
11.4.1 Forschung und Entwicklung Company Detail
11.4.2 Forschung und Entwicklung Business Overview
11.4.3 Forschung und Entwicklung Acute Lung Injury Introduction
11.4.4 Forschung und Entwicklung Revenue in Acute Lung Injury Business (2019-2024)
11.4.5 Forschung und Entwicklung Recent Development
11.5 Commence Bio
11.5.1 Commence Bio Company Detail
11.5.2 Commence Bio Business Overview
11.5.3 Commence Bio Acute Lung Injury Introduction
11.5.4 Commence Bio Revenue in Acute Lung Injury Business (2019-2024)
11.5.5 Commence Bio Recent Development
11.6 CompleGen
11.6.1 CompleGen Company Detail
11.6.2 CompleGen Business Overview
11.6.3 CompleGen Acute Lung Injury Introduction
11.6.4 CompleGen Revenue in Acute Lung Injury Business (2019-2024)
11.6.5 CompleGen Recent Development
11.7 Histocell S.L.
11.7.1 Histocell S.L. Company Detail
11.7.2 Histocell S.L. Business Overview
11.7.3 Histocell S.L. Acute Lung Injury Introduction
11.7.4 Histocell S.L. Revenue in Acute Lung Injury Business (2019-2024)
11.7.5 Histocell S.L. Recent Development
11.8 Stemedica Cell Technologies
11.8.1 Stemedica Cell Technologies Company Detail
11.8.2 Stemedica Cell Technologies Business Overview
11.8.3 Stemedica Cell Technologies Acute Lung Injury Introduction
11.8.4 Stemedica Cell Technologies Revenue in Acute Lung Injury Business (2019-2024)
11.8.5 Stemedica Cell Technologies Recent Development
11.9 Windtree Therapeutics
11.9.1 Windtree Therapeutics Company Detail
11.9.2 Windtree Therapeutics Business Overview
11.9.3 Windtree Therapeutics Acute Lung Injury Introduction
11.9.4 Windtree Therapeutics Revenue in Acute Lung Injury Business (2019-2024)
11.9.5 Windtree Therapeutics Recent Development
11.10 S-Evans Biosciences
11.10.1 S-Evans Biosciences Company Detail
11.10.2 S-Evans Biosciences Business Overview
11.10.3 S-Evans Biosciences Acute Lung Injury Introduction
11.10.4 S-Evans Biosciences Revenue in Acute Lung Injury Business (2019-2024)
11.10.5 S-Evans Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
